Portfolio company
Karius
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Karius develops genomic blood tests that identify pathogens to help clinicians diagnose infectious diseases in patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Delve Bio
This company provides metagenomic next-generation sequencing tests and diagnostic software to clinicians and laboratories for identifying pathogens in infectious diseases.
Claryx
Claryx develops a genomic surveillance platform that sequences pathogen DNA to detect and trace infection outbreaks for hospitals and healthcare systems.
Noscendo
This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.
Biotia
This company develops genomic sequencing software and diagnostic tests to identify infectious diseases for hospitals, researchers and patients.
Novus Diagnostic
Novus Diagnostics develops point-of-care diagnostic devices for clinicians to detect and classify bloodstream infections, specifically sepsis, within fifteen minutes at the bedside.
Anvil Diagnostics
This company develops molecular blood tests to identify and quantify pathogens in hospitalised patients using digital PCR hardware.
Qvella
Qvella develops molecular diagnostic platforms for rapid pathogen detection in whole blood samples to assist clinicians with infection management.
Deepull
Deepull develops automated diagnostic systems that identify pathogens and antibiotic resistance directly from blood samples for healthcare providers treating sepsis and acute infections.
